Related Experiment Video

Updated: Dec 24, 2025

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

339

Metabolic Reprogramming by c-MET Inhibition as a Targetable Vulnerability in Glioblastoma

Trang Thi Thu Nguyen1, Enyuan Shang2, Georg Karpel-Massler3

  • 1Department of Pathology & Cell Biology, Columbia University Medical Center, New York, New York, USA.

Oncoscience
|April 8, 2020
PubMed

Insights

Targeting fatty acid oxidation, driven by c-MET inhibition, offers a new therapeutic strategy for malignant glial tumors. This approach enhances understanding of treatment resistance in solid tumors.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Molecular Biology

Background:

  • Developing effective treatments for solid tumors, particularly malignant glial tumors, remains a significant challenge.
  • Understanding the molecular mechanisms of treatment response and resistance is crucial for therapeutic success.
  • Novel tools for interrogating tumor cell metabolism have recently emerged, offering greater precision.

Purpose of the Study:

  • To investigate the metabolic effects of c-MET inhibition in solid tumors.
  • To identify potential therapeutic targets based on metabolic alterations.
  • To explore the role of fatty acid oxidation in treatment resistance.

Main Methods:

  • Utilized extracellular flux analysis to measure cellular metabolic activity.
  • Employed carbon tracing techniques to track metabolic pathways.
  • Investigated the effects of acute and chronic c-MET inhibition.

Main Results:

  • Observed that c-MET inhibition significantly increases fatty acid oxidation in tumor cells.
  • Demonstrated that this induced fatty acid oxidation can be therapeutically targeted.
  • Identified a potential vulnerability for combination therapies.

Conclusions:

  • Acute and chronic c-MET inhibition promotes fatty acid oxidation.
  • Targeting fatty acid oxidation presents a promising strategy for combination therapies against malignant glial tumors.
  • Further research into metabolic reprogramming in cancer is warranted.
Keywords:
Fatty Acid OxidationGlioblastomaMetabolic Reprogrammingc-MET

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.4K
Translational Orthotopic Models of Glioblastoma Multiforme07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.5K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K